Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study
Clinical trial NCT03701711 · TERMINATED
Trial details
- NCT number
- NCT03701711
- Sponsor
- Ohio State University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2022-02-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.